Liver cancer drug combo safety checked in 1,200 patients
NCT ID NCT05667064
First seen Mar 17, 2026 · Last updated May 24, 2026 · Updated 13 times
Summary
This study looked at the safety of two drugs (IMJUDO and IMFINZI) given together or alone to 1,200 people with advanced liver cancer that cannot be removed by surgery. The goal was to track side effects in real-world use, not to cure the disease. Participants received these treatments as part of their regular care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.